Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 62 results found. Search for [ By-E.-Kumar-Sharma ]

Results 1 to 21 of 62
By E Kumar Sharma
February 1, 2017
It was a budget which seem to be finally stating action in the healthcare sector. Finance minister Arun Jaitley, many in the sector felt, began well when he said: \"Action plan has been prepared to eliminate Kala azar, Filariasis by 2017, leprosy by 2018, measles by 2020 and elimination of tuberculosis by 2025.\"


By E Kumar Sharma
January 25, 2017
Apollo Sugar, the chain of speciality clinics  focused on prevention and management of diabetes, launched as a specialized vertical by Apollo Hospitals in September 2014, is being tweaked with new facets being added to its business model and delivery formats.


by E Kumar Sharma
Delhi, January 21, 2017
Top pharma companies - Driven by inorganic growth opportunities - are also learning to live with more debt.


by E. Kumar Sharma
Delhi, December 26, 2016
Tech-savvy health care is making a difference to both the well-off and those with limited resources and access.


by E. Kumar Sharma
Delhi, December 26, 2016
With criminals spreading their web in cyberspace, efficient and effective policing is making it imperative to master new digital tools.


by E. Kumar Sharma
Delhi, December 26, 2016
E-governance is the watchword in Andhra Pradesh and Telangana, both of which have launched unique digital initiatives.


By E Kumar Sharma
December 6, 2016
The passing away of Tamil Nadu chief minister J Jayalalithaa is a major development for industry operating in Tamil Nadu and those considering new investments into the state.


By E Kumar Sharma
November 27, 2016
Thanks to demonetisation, operations for most microfinance institutions have come to a near standstill. Loan disbursements and their repayments have almost  stopped for many microfinance institutions (MFIs) and therefore, in a sense, the  Indian microfinance sector is largely on a holiday.


By E Kumar Sharma
November 27, 2016
Demonetisation has had another side effect - patients are stocking up medicines for the next two to three months. This is especially so for ailments where life-long mediations are required such as for diabetes or hypertension - called chronic therapy areas in medical lingo.


By E. Kumar Sharma
Delhi, November 26, 2016
Sale of online prescription drugs could be great news for the customer, but monitoring e-pharmacies effectively will be a challenge.


By E Kumar Sharma
Delhi, November 12, 2016
Equipping students with skills to work in diverse environments and handle dynamic situations is becoming increasingly important.


By E Kumar Sharma
Delhi, November 12, 2016
Any change in the drug price control regime purely for ease of doing business can have serious ramifications.


By E Kumar Sharma
Delhi, November 17, 2016
The 2016 edition of the BT-MDRA Best B-schools survey comes in the backdrop of renewed faith in traditional sectors such as consulting, FMCG, marketing and manufacturing, and offers deep insights.


By E. Kumar Sharma,E Kumar Sharma
Delhi, October 29, 2016
Many major pharma stocks, seen as safe bets in the worst of times, have seen their market caps slip in the past year. Is pharma losing its sheen on the bourses?


By E. Kumar Sharma
Delhi, September 17, 2016
Pullela Gopichand, Chief National Badminton Coach, whose guidance led P.V. Sindhu and Saina Nehwal to win Olympic medals, talks to E. Kumar Sharma on what it takes to nurture talent.


By E. Kumar Sharma
Delhi, September 25, 2016
There are lessons for Indian pharma companies from the drug pricing concerns in the US.


By E. Kumar Sharma
Delhi, August 22, 2016
India's favourite home-grown toon character, Chhota Bheem, is evolving, gaining new powers and getting a new storyline. Can the mighty kid woo more viewers in a competitive market?


By E Kumar Sharma
Delhi, August 19, 2016
The fact that the $8-billion Fosun Group was keen on the US market makes the deal special, given that 62 per cent of Gland Pharma's revenues of $169 million in 2015 came from the US, compared to 16 per cent from India and the rest from other geographies.


By E. Kumar Sharma
Delhi, July 23, 2016
Indian drug makers are slugging it out with Big Pharma over launch of biosimilars. Will they be able to hold their fort in this emerging space?


By E. Kumar Sharma
Delhi, May 14, 2016
Bharat Biotech claims progress on a vaccine for Zika virus. However, this raises several questions.


PAGES 1 OF 4  1234